Anders Wanhainen, MD, PhD
Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Tuesday, November 19, 2019 |
Presenter
Why Are AAA Patients Surviving More: What Is Its Impact On Screening And Size Criteria For Repair
1:12 PM - 1:17 PM
|
Presenter
Value Of Metformin And Ticagrelor In Inhibiting The Growth Of Small AAAs: What Is The Long-Term Fate Of 25-29 mm Abdominal Aortas: How Many Will Become AAAs
1:18 PM - 1:23 PM
|
Wednesday, November 20, 2019 |
Presenter
Screening For Vascular Diseases Can Cause More Harm Than Benefit: How To Avoid This Problem
3:05 PM - 3:10 PM
|
Presenter
Increasing Role Of Endovascular Treatments And EVAR For Vascular Complications Of Connective Tissue Disorders
3:25 PM - 3:30 PM
|
Thursday, November 21, 2019 |
Presenter
EVAR Outcomes Are Improving In RAAA Patients: EVAR Should Be The Standard Of Care In Most RAAA Patients: Which RAAA Patients Currently Should Get Open Repair
1:30 PM - 1:35 PM
|
Friday, November 22, 2019 |
Presenter
For Mycotic AAAs, Why Is EVAR Better Than Open Repair: It Provides Better Short-Term Survival With No Long-Term Disadvantages: Technical Tips
8:14 AM - 8:19 AM
|
previous | next |